Diabetes: 100 years since Sheffield made medical history as first patient was treated with insulin

Before then, diabetes was effectively a 'death sentence', with the only treatments being starvation diets
Watch more of our videos on Shots! 
and live on Freeview channel 276
Visit Shots! now

It is 100 years since a major medical milestone was recorded in Sheffield which would change the lives of millions of people living with diabetes.

The first person in England to be treated with insulin was Sir Stuart Goodwin, a leading figure in Sheffield's steel industry and a celebrated philanthropist.

Sir Stuart Goodwin was the first person in England to be treated with insulin, in 1923, at the University of Sheffield’s Medical SchoolSir Stuart Goodwin was the first person in England to be treated with insulin, in 1923, at the University of Sheffield’s Medical School
Sir Stuart Goodwin was the first person in England to be treated with insulin, in 1923, at the University of Sheffield’s Medical School
Hide Ad
Hide Ad

He was treated with insulin at the University of Sheffield’s Medical School in 1923, at a time when a diabetes diagnosis was essentially a 'death sentence', with life expectancy at one to two years at most.

The only treatments for diabetes before then were starvation diets, such as the Allen diet which restricted a patient’s intake to as little as 400 calories in 24 hours.

But Sir Stuart paid to be included in a clinical trial for insulin, and after six months was back at work and unrecognisable to colleagues.

While being treated, he also showed goodwill to others and paid for a number of other patients to be treated.

Hide Ad
Hide Ad

Professor Sheila Francis, from the University of Sheffield’s School of Medicine and Population Health, told the PA news agency: “Now we talk about complications and effects on the eyes and effects on the feet.

'Diabetes was a death sentence'

“But none of those things really happened because people didn’t live long enough. So really, it was a death sentence.

“Basically, it was a death sentence because it was just managed using starvation diets up until the point that that insulin was used, so people didn’t live very long at all.”

She added: “There’s a strong thread of goodwill throughout the story, in that Goodwin was accepted onto the clinical trial.

Hide Ad
Hide Ad

“So goodwill was shown to Goodwin and then he showed goodwill to the people of Sheffield by funding their treatment.

“And then he followed on with major philanthropic donations within the city and within the UK."

Philanthropist funded diabetes treatment for people of Sheffield

Prof Francis added that Sir Stuart, born in 1886, was probably diagnosed with type 1 diabetes when he was in his 30s, but thanks to the insulin treatment went on to live until he was 83.

She explained that recent archive searches revealed the treatment most likely started in February.

Hide Ad
Hide Ad

The insulin used in the trial in 1923 was made in Sheffield using pancreatic tissue from cows.

One year earlier, a young boy was treated in Toronto, Canada, but the discovery was made in 1921.

The first UK person was treated in Edinburgh in August 1922.

More than 1 million people in UK rely on insulin

According to Diabetes UK, today more than one million people in the UK rely on insulin.

Hide Ad
Hide Ad

Hannah Postles, 38, from Sheffield was diagnosed with type 1 diabetes aged 26.

She said: “I was diagnosed with type one diabetes in December 2011 and, since then, have needed to inject myself with insulin up to five times every day to stay alive.

“Diabetes care has progressed so much since those first clinical trials in Sheffield 100 years ago, and even in the 12 years since I was diagnosed.

“I used to have to prick my finger to test my blood glucose, but I now wear a sensor on my arm that automatically sends my readings to my phone.

Diabetes care continues to progress

Hide Ad
Hide Ad

“I will soon be moving to an insulin pump instead of giving myself insulin injections, and my pump and sensor will communicate with each other to help keep my blood glucose levels in a healthy range.

“It is remarkable to think that, while type one diabetes was a death sentence for patients before the discovery and first clinical trials of insulin, we are at a point 100 years later where more and more patients are able to access technology that essentially gives them an ‘artificial pancreas’.

“These improvements make a real difference to people’s lives, reducing the burden of living with a condition that can be so difficult and exhausting to manage.

“As someone who receives their diabetes care in Sheffield, I feel really proud that the city and university played such a critical role in the first British clinical trials of insulin, and am grateful to everyone involved in the research that has taken place since then.”

Hide Ad
Hide Ad

However, Prof Francis said more needs to be done across the world to ensure equal access to the life saving treatment.

She explained: “I think we’re always striving to get equal access across the world for these different medicines, and pharmaceutical companies should be making arrangements to make insulin available across the world at a reasonable price, it’s one of the most successful drugs of all time.”

A Diabetes UK spokesman said: “Before insulin was discovered, type 1 diabetes was a death sentence, people didn’t live for more than one or two years.

“The discovery of insulin was revolutionary and it has saved millions of lives worldwide, turning a fatal condition into something that can be managed.

Hide Ad
Hide Ad

“In the years since this breakthrough, we’ve learnt an incredible amount about the immune system’s role in type 1 diabetes and the potential consequences the condition has on people’s health and wellbeing.

“Diabetes UK is committed to funding research that will lead to new treatments and eventually a cure for people with type 1 diabetes, where insulin as the only therapy for the condition is a thing of the past.”

Comment Guidelines

National World encourages reader discussion on our stories. User feedback, insights and back-and-forth exchanges add a rich layer of context to reporting. Please review our Community Guidelines before commenting.